Page URL: https://www.bionews.org.uk/page_95190

'Flu severity' gene identified

14 September 2015
Appeared in BioNews 819

A key gene that governs the severity of influenza infections has been identified. Scientists predict that this finding might lead to a new class of antiviral drugs capable of targeting a range of different infections, the British Science Festival heard last week.

By studying samples from the 2009 swine flu outbreak, researchers noticed a strong relationship between severity of influenza symptoms and variants in a gene called IFIT3. Around one in 400 people carries a variant named rs12552, which makes them more likely to experience severe, and sometimes fatal, illness when they are infected with the influenza virus.

Professor Paul Kellam of the Wellcome Trust Sanger Institute near Cambridge said: 'When you have this variant you have a four- to five-fold increased chance of severe influenza when exposed to a virus that is otherwise causing mild or no disease in the wider population.'

IFIT3 works by strengthening cell walls to prevent viruses from entering and infecting the cell. This defence is impaired in people who carry the rs12552 gene variant. Early signs are that drugs that increase the activity of IFIT3 may be effective treatments for other viral diseases as well.

'By understanding genetic variants like this we can start to think about broad-spectrum antivirals that hit a whole range of viruses, from flu to dengue and Ebola,' commented Professor Kellam.

'We have broad-spectrum antibiotics that work against a range of bacteria... This could lead to a broad-spectrum antiviral, though it would work by altering human cells rather than targeting the virus directly,' he added.

Although such treatments are an estimated five to ten years away, the discovery of the IFIT3 gene variant has more immediate implications for health. During flu epidemics, rapid testing for the rs12252 variant in hospital emergency departments could help to identify people at risk of developing severe influenza and prioritise them for treatment.

Using the test in healthy people could also lead to a personalised approach to influenza vaccination. At present, an annual flu vaccine is recommended for groups such as the over- 65s, pregnant women and people with chronic medical conditions, who are believed to be at greater risk of influenza complications. Identifying those who are genetically susceptible could help doctors to decide more accurately who should receive influenza vaccination.

SOURCES & REFERENCES
Could the answer to fighting the flu virus lie in our genes?
British Science Association (press release) |  8 September 2015
Discovery of 'Achilles heel' of viruses paves way for drugs to combat flu, yellow fever and Ebola
The Independent |  8 September 2015
Scientists discover 'flu severity' gene
Financial Times |  8 September 2015
Scientists hail 'antibiotic for viruses' which could see one drug used to fight off flu, Ebola and yellow fever
Daily Mail |  8 September 2015
Serious flu risk could be identified with genetic test
The Guardian |  8 September 2015
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
19 June 2017 - by Helen Robertson 
Scientists have identified three potential genetic mutations that could allow a dangerous strain of avian influenza to spread between humans...
27 February 2017 - by Annabel Slater 
Scientists have identified a 'hidden code' of key DNA sequences in a virus from the same family as the common cold...
22 February 2016 - by Ayala Ochert 
The Human Fertilisation and Embryology Authority is recommending that people returning from Zika-virus prone areas should not try to conceive naturally, donate eggs or sperm, or proceed with fertility treatment for 28 days...
30 March 2015 - by Dr James Heather 
A report has found that rare mutations in a single gene made one girl genetically susceptible to severe influenza infection...
23 March 2015 - by Fiona Ibanichuka 
A dispute has arisen between US scientists and Indian health officials over the virulence of the H1N1 swine flu virus...
8 December 2014 - by Fiona Ibanichuka 
The US Centers for Disease Control has released a health advisory warning clinicians that flu vaccines will have diminished effectiveness against one strain currently circulating in the US as it has mutated to become resistant...
3 June 2013 - by Dr Anna Cauldwell 
A gene therapy technique can protect mammals from lethal strains of influenza, according to US researchers...
4 February 2013 - by Matthew Thomas 
A genetic variant frequently found in Chinese populations may explain why severe complications from swine flu are more common in China. The discovery may also have implications for other influenza virus strains and help scientists understand why flu outbreaks hit some populations harder than others....
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.